Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

A whale with a lot of money to spend has taken a noticeably bullish stance on Skyworks Solutions. Looking at options history for Skyworks Solutions (NASDAQ:SWKS) we detected 12 strange trades.

Benzinga

We Asked, You Answered: What Stock Would You Never Buy Again?

Almost all traders have had that moment: A confident stock pick or strategy that backfires and leaves the investor with less money than they had before and vowing never to trade that stock again.

Benzinga

Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today

GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 8.17% at $9.80

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Bullish Sentiment Across The Cannabis Space - Check Full Movers For May 2, 2022

GAINERS: GrowGeneration (NASDAQ:GRWG) shares closed up 9.14% at $6.45

Benzinga

$1000 Invested In T. Rowe Price Gr 20 Years Ago Would Be Worth This Much

T. Rowe Price Gr (NASDAQ:TROW) has outperformed the market over the past 20 years by 3.1% on an annualized basis producing an average annual return of 10.04%. Currently, T. Rowe Price Gr has a market capitalization of $28.37 billion.

Benzinga

Preview: Veracyte's Earnings

Veracyte (NASDAQ:VCYT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Veracyte will report an earnings per share (EPS) of $-0.24.

Benzinga

Masimo's Earnings Outlook

Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an earnings per share (EPS) of $0.87.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Viant Technology's Earnings: A Preview

Viant Technology (NASDAQ:DSP) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Viant Technology will report an earnings per share (EPS) of $-0.23.

Benzinga

7 Analysts Have This to Say About Bloomin Brands

Over the past 3 months, 7 analysts have published their opinion on Bloomin Brands (NASDAQ:BLMN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Amazon Workers Vote Against Unionizing Second Warehouse; Company To Get Hearing That Could Overturn First Union Vote

Amazon.com, Inc (NASDAQ:AMZN) workers have voted against unionizing a second warehouse in New York City in the borough of Staten Island, known as LDJ5, with 618 to 380 against joining the Labor Union, Reuters reported. The turnout was 61%, It could slow the momentum for labor union advocates that demanded better pay…

Benzinga

Preview: Paramount Global's Earnings

Paramount Global (NASDAQ:PARAA) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Paramount Global will report an earnings per share (EPS) of $0.52.

Benzinga

Markets Rally Into Close To Get New Month Started On Positive Note

U.S. indices rallied into Monday's close as stocks recovered following Friday's weakness. Federal Reserve rate hike concerns, the Russia-Ukraine conflict, China COVID cases and earnings have pressured markets in recent sessions. The ISM manufacturing PMI dropped for a second straight month to 55.4 in April from 57.1 in March. Analysts…

Benzinga

Infinity Pharmaceuticals Earnings Preview

Infinity Pharmaceuticals (NASDAQ:INFI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Infinity Pharmaceuticals will report an earnings per share (EPS) of $-0.13.

Benzinga

Analyst Ratings for Ballard Power Systems

Over the past 3 months, 4 analysts have published their opinion on Ballard Power Systems (NASDAQ:BLDP) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Veru Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Veru. Looking at options history for Veru (NASDAQ:VERU) we detected 21 strange trades.

Benzinga

Analyzing Better Therapeutics's Short Interest

Better Therapeutics's (NASDAQ:BTTX) short percent of float has fallen 82.14% since its last report. The company recently reported that it has 35.00 thousand shares sold short, which is 0.45% of all regular shares that are available for trading.

Benzinga

Where Regeneron Pharmaceuticals Stands With Analysts

Analysts have provided the following ratings for Regeneron Pharmaceuticals (NASDAQ:REGN) within the last quarter:

StockNews.com

3 High-Quality Stocks to Buy During This Market Selloff

The near-term market outlook remains cloudy. While the S&P 500 is about 3% above its late-February lows, the Nasdaq and Russell 2000 have already undercut these levels. Below are 3 such stocks that investors should consider buying during this market correction: Anthem (ANTM), Pfizer (PFE), and Builders FirstSource (BLDR).

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

How Expedia Group Stock Looks Heading Into Q1 Earnings Print

Expedia Group, Inc (NASDAQ: EXPE) is set to print its first-quarter financial results after the market close. The stock was trading slightly lower heading into the event and remains down over 20% from the Feb. 16 all-time high of $217.72.

Benzinga

Here's Why This Analyst Cut Price Target On Regeneron

RBC Capital Markets has lowered Regeneron Pharmaceuticals Inc's price target (NASDAQ:REGN) from $679 to $647 and maintained a Sector Perform rating. Checks suggest that Dupixent (dupilumab) growth/durability should remain strong in new and existing indications, maintaining positive sentiment. The analysts also believe that the concerns about near-term Eylea competition may be overblown. However, high-dose…

Benzinga

Why RBC Capital Sees 'Multiple High-Risk' On This Neurology-Focused Stock

RBC Capital Markets writes that Prothena Corporation plc (NASDAQ: PRTA) believes that the recent stock downside provides an entry point and that progress with the programs and improved sentiment in the space could drive appreciation.

Benzinga

Mid-Afternoon Market Update: Nasdaq Gains 100 Points; First Wave BioPharma Shares Plunge

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 100 points on Monday.

Benzinga

12 Information Technology Stocks Moving In Monday's Intraday Session

Benzinga

12 Industrials Stocks Moving In Monday's Intraday Session

Benzinga

10 Consumer Discretionary Stocks Moving In Monday's Intraday Session

1 … 599 600 601 602

People

Jaimini DesaiJaimini Desai

59 stories

Jaimini Desai

10 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.